# A Study of the Epidemiology and Hospital Management of Patients With PROS in France

> **NCT07222423** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 3605 (actual)

## Conditions studied

- PIK3CA-Related Overgrowth Spectrum

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07222423
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-15
- **Primary completion:** 2024-10-08
- **Final completion:** 2024-10-08
- **Target enrollment:** 3605 (ACTUAL)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07222423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07222423, "A Study of the Epidemiology and Hospital Management of Patients With PROS in France". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07222423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*